Date published: 2025-9-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

SB144 Inhibitors

SB144 inhibitors belong to a specialized class of chemical compounds designed to selectively interact with specific biological targets. The designation "SB144" typically refers to a particular molecular framework or a key functional moiety that characterizes this group of inhibitors. These molecules are synthesized through a series of organic reactions, which are meticulously designed to introduce the necessary chemical groups that confer both the inhibitory function and the specificity of the compound. The synthetic journey of these inhibitors involves a strategic assembly of atom clusters, which may include heterocyclic structures, aromatic rings, and various substituents that are essential for the biological activity of these compounds.

The specificity of SB144 inhibitors is achieved through a fine-tuned molecular architecture that allows them to engage with their target with high affinity. This precise interaction is the result of an extensive structure-activity relationship study, where small modifications to the chemical structure can lead to significant changes in the way these inhibitors interact with their target. The binding affinity is dictated by non-covalent interactions such as hydrogen bonding, hydrophobic forces, van der Waals interactions, and sometimes ionic bonds. The molecular surface of SB144 inhibitors is often complementary to that of their target, enabling a snug fit that stabilizes the inhibitor-target complex. Advanced techniques like X-ray crystallography, NMR spectroscopy, and computational modeling play pivotal roles in understanding the three-dimensional conformation of these inhibitors and in guiding the optimization of their interaction profiles. By focusing on the design and structural attributes of SB144 inhibitors, researchers can refine these compounds to achieve the desired level of selectivity and potency.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Palbociclib

571190-30-2sc-507366
50 mg
$315.00
(0)

A selective inhibitor of CDK4/6, which are crucial for cell cycle progression. SB144, if related to cell cycle control, would be indirectly inhibited as Palbociclib halts the cell cycle, potentially reducing the need for SB144 activity.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$112.00
$163.00
$928.00
19
(1)

An inhibitor of MEK1/2, which are part of the MAPK/ERK signaling pathway that regulates cell proliferation. By inhibiting this pathway, the activity of SB144 may be indirectly diminished if SB144 acts downstream or is modulated by MAPK signaling.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor that disrupts the PI3K/Akt signaling pathway, often implicated in cell survival and growth. If SB144 activity is associated with this pathway, LY294002 could lead to reduced SB144 function.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor that can suppress cell growth and proliferation. Should SB144 be involved in mTOR signaling, Rapamycin would indirectly decrease its functional activity.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

An EGFR inhibitor that blocks signaling pathways involved in cell proliferation. If SB144 is activated by EGFR signaling, Gefitinib could inhibit its activity.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

A proteasome inhibitor that can disrupt multiple cellular processes, including those that may involve SB144, leading to decreased protein activity.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

A modulator of the ubiquitin ligase complex, which can alter protein degradation pathways. If SB144 stability is regulated by ubiquitination, Thalidomide might indirectly inhibit its activity.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

A tyrosine kinase inhibitor that may inhibit angiogenesis and cell proliferation. If SB144 functions are related to these processes, Sorafenib could lead to decreased activity.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

A BCR-ABL tyrosine kinase inhibitor that also affects other kinases. If SB144 activity depends on such kinases, Imatinib could indirectly inhibit it.

Vemurafenib

918504-65-1sc-364643
sc-364643A
10 mg
50 mg
$115.00
$415.00
11
(1)

A BRAF inhibitor that may inhibit SB144 if it is associated with the BRAF/MEK/ERK pathway, leading to decreased activity.